An international survey on withdrawing the ketogenic diet therapy for epilepsy
KDT weaning remains a heterogeneous and under-studied aspect of treatment. Despite variations in protocols, common themes include cautious tapering and syndrome-specific considerations. These findings highlight the need for prospective studies to establish evidence-based data for KDT discontinuation.
Authors
- Jong M. Rho (ORCID: https://orcid.org/0000-0001-9886-9924)
- Blandine Dozières‐Puyravel (ORCID: https://orcid.org/0000-0002-2857-1767)
- Eric H. Kossoff (ORCID: https://orcid.org/0000-0002-5260-5314)
- Anita Devlin (ORCID: https://orcid.org/0000-0002-3814-4777)
- Stéphane Auvin (ORCID: https://orcid.org/0000-0003-3874-9749)
- Natasha E. Schoeler (ORCID: https://orcid.org/0000-0001-6202-1497)
- Elles van der Louw (ORCID: https://orcid.org/0000-0003-3245-0471)
- Sophie Höhn (ORCID: https://orcid.org/0000-0003-2668-2428)
- Noémie Donnard
Institutions
- Johns Hopkins University (US)
- Inserm (FR)
- Université Paris Cité (FR)
- Johns Hopkins Medicine (US)
- Great Ormond Street Hospital (GB)
- Erasmus MC (NL)
- Yale University (US)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hôpital Robert-Debré (FR)
- Great North Children's Hospital (GB)
- NeuroDiderot (FR)
- University College London (GB)
- Erasmus University Rotterdam (NL)
Publication Details
- Journal
- Epilepsy & Behavior
- Published
- 2025-05-28
- DOI
- https://doi.org/10.1016/j.yebeh.2025.110481
- Citations
- 2
- Primary Topic
- Diet and metabolism studies
- Type
- article
- Field-Weighted Citation Impact
- 2.33
Funders
- Agence Nationale de la Recherche